Skip to content

Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai

Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04023201
Acronym
NQPDSH
Enrollment
1500
Registered
2019-07-17
Start date
2019-07-03
Completion date
2020-01-31
Last updated
2019-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Brief summary

This is a cross-sectional, retrospective clinical observation study focusing on the incidence and influencing factors of nocturnal symptoms in patients with Parkinson's disease.

Detailed description

This study was a cross-sectional, retrospective clinical observation study investigating the incidence and influencing factors of nocturnal symptoms in patients with Parkinson's disease through the Parkinson's disease sleep-related scale. At the same time, the effects of nocturnal symptoms on the quality of life of patients with Parkinson's disease were studied. About 1,500 Parkinson's patients will be recruited into the study who come from Shanghai, China.

Interventions

OTHERNocturnal symptoms

Parkinson's disease patients with or without nocturnal symptoms

Sponsors

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Parkinson's disease patients diagnosed according to the diagnostic criteria of MDS 2. Signing informed consent

Exclusion criteria

1. clinically suspected Parkinson's disease, has not been diagnosed; 2. suspected or diagnosed as secondary Parkinson's syndrome (vascular, drug, traumatic, encephalitis, toxic, etc.); 3. suspected or diagnosed as atypical Parkinson's syndrome (progressive supranuclear palsy, multiple system atrophy, cortical basal ganglia degeneration, etc.); 4. There is a clear history of stroke, moderate to severe traumatic brain injury, hydrocephalus, brain surgery or history of brain tumors; 5. severe cognitive impairment or psychiatric symptoms; 6. Can not cooperate with the completion of the study.

Design outcomes

Primary

MeasureTime frameDescription
nocturnal symptoms in patients with Parkinson's diseaseJanuary 31, 2020the incidence and influencing factors of nocturnal symptoms in patients with Parkinson's disease

Countries

China

Contacts

Primary ContactYu Zhang
zhangyu0330@126.com8613916006909

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026